{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:21:02Z","timestamp":1790734862152,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T00:00:00Z","timestamp":1654560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s12350-022-03000-w","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T22:02:49Z","timestamp":1654639369000},"page":"3332-3340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Phenotype-based management of coronary microvascular dysfunction"],"prefix":"10.1016","volume":"29","author":[{"given":"Daniel Tze Yee","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Carlos","family":"Kaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-022-03000-w_bib1","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet (London, England)"},{"key":"10.1007\/s12350-022-03000-w_bib2","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa0907272","article-title":"Low diagnostic yield of elective coronary angiography","volume":"362","author":"Patel","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1007\/s12350-022-03000-w_bib3","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.jacc.2010.01.054","article-title":"Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women\u2019s ischemia syndrome evaluation) study","volume":"55","author":"Pepine","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"10.1007\/s12350-022-03000-w_bib4","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1093\/eurheartj\/ehr331","article-title":"Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events","volume":"33","author":"Jespersen","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-03000-w_bib5","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1016\/j.jacc.2018.09.006","article-title":"stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial","volume":"72","author":"Ford","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jcin.2015.06.017","article-title":"Prevalence of coronary microvascular dysfunction among patients with chest pain and nonobstructive coronary artery disease","volume":"8","author":"Sara","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1007\/s12350-022-03000-w_bib7","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1093\/eurheartj\/ehaa503","article-title":"An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in Collaboration with European Society of Cardiology Working Group on coronary pathophysiology & microcirculation endorsed by Coronary Vasomotor Disorders International","volume":"41","author":"Kunadian","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1007\/s12350-022-03000-w_bib8","first-page":"117","article-title":"Natural history of patients with insignificant coronary artery disease","volume":"2","author":"Tavella","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-03000-w_bib9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1001\/jama.2014.14681","article-title":"Nonobstructive coronary artery disease and risk of myocardial infarction","volume":"312","author":"Maddox","year":"2014","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1007\/s12350-022-03000-w_bib10","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/jamacardio.2019.0014","article-title":"Baseline characteristics and risk profiles of participants in the ISCHEMIA randomized clinical trial","volume":"4","author":"Hochman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1161\/CIRCULATIONAHA.120.046791","article-title":"Natural history of patients with ischemia and no obstructive coronary artery disease: the CIAO-ISCHEMIA study","volume":"144","author":"Reynolds","year":"2021","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Neumann","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-03000-w_bib13","first-page":"e368","article-title":"2021 AHA\/ACC\/ASE\/CHEST\/SAEM\/SCCT\/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"144","author":"Gulati","year":"2021","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcin.2019.11.001","article-title":"1-Year outcomes of angina management guided by invasive coronary function testing (CorMicA)","volume":"13","author":"Ford","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1007\/s12350-022-03000-w_bib15","unstructured":"Stratified medicine methodology framework\u2014Research\u2014Medical Research Council [cited 2021 May 23]. Available from: https:\/\/mrc.ukri.org\/research\/initiatives\/precision-medicine\/stratified-medicine-methodology-framework\/."},{"key":"10.1007\/s12350-022-03000-w_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/03630242.2019.1643817","article-title":"Gender differences in symptom misattribution for coronary heart disease symptoms and intentions to seek health care","volume":"60","author":"Biddle","year":"2020","journal-title":"Women Health"},{"key":"10.1007\/s12350-022-03000-w_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ijcard.2017.08.068","article-title":"International standardization of diagnostic criteria for microvascular angina","volume":"250","author":"Ong","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0002-9343(59)90003-8","article-title":"Angina pectoris I. A variant form of angina pectoris. Preliminary report","volume":"27","author":"Prinzmetal","year":"1959","journal-title":"Am J Med."},{"key":"10.1007\/s12350-022-03000-w_bib19","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1161\/01.CIR.74.6.1255","article-title":"Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina","volume":"74","author":"Kaski","year":"1986","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib20","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/0735-1097(89)90382-3","article-title":"Spontaneous coronary artery spasm in variant angina is caused by a local hyperreactivity to a generalized constrictor stimulus","volume":"14","author":"Kaski","year":"1989","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib21","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCULATIONAHA.113.004096","article-title":"Clinical usefulness, angiographic characteristics, and safety evaluation of intracoronary acetylcholine provocation testing among 921 consecutive white patients with unobstructed coronary arteries","volume":"129","author":"Ong","year":"2014","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib22","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacc.2011.11.015","article-title":"High prevalence of a pathological response to acetylcholine testing in patients with stable angina pectoris and unobstructed coronary arteries The ACOVA Study (Abnormal COronary VAsomotion in patients with stable angina and unobstructed coronary arteries","volume":"59","author":"Ong","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jjcc.2016.09.012","article-title":"Overview of the pharmacological spasm provocation test: Comparisons between acetylcholine and ergonovine","volume":"69","author":"Sueda","year":"2017","journal-title":"J Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib24","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ijcard.2017.05.109","article-title":"Safety of intracoronary provocative testing for the diagnosis of coronary artery spasm","volume":"1","author":"Ciliberti","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(97)07329-7","article-title":"Angina pectoris caused by coronary microvascular spasm","volume":"351","author":"Mohri","year":"1998","journal-title":"Lancet (London, England)."},{"key":"10.1007\/s12350-022-03000-w_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S0735-1097(02)01690-X","article-title":"Coronary microvascular spasm causes myocardial ischemia in patients with vasospastic angina","volume":"39","author":"Sun","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1007\/s12350-022-03000-w_bib27","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.atherosclerosis.2014.07.009","article-title":"Coronary microvascular spasm triggers transient ischemic left ventricular diastolic abnormalities in patients with chest pain and angiographically normal coronary arteries","volume":"236","author":"Arrebola-Moreno","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1007\/s12350-022-03000-w_bib28","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1253\/circj.CJ-66-0098","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013)","volume":"78","year":"2014","journal-title":"Circ J"},{"key":"10.1007\/s12350-022-03000-w_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008126","article-title":"Ischemia and no obstructive coronary artery disease: prevalence and correlates of coronary vasomotion disorders","author":"Ford","year":"2019","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1007\/s12350-022-03000-w_bib30","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jcmg.2018.12.022","article-title":"Automated pixel-wise quantitative myocardial perfusion mapping by CMR to detect obstructive coronary artery disease and coronary microvascular dysfunction: validation against invasive coronary physiology","volume":"12","author":"Kotecha","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03000-w_bib31","article-title":"What an interventionalist needs to know about INOCA","author":"Ang","year":"2021","journal-title":"Interv Cardiol Rev Res Resour"},{"key":"10.1007\/s12350-022-03000-w_bib32","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/eurheartj\/ehs199","article-title":"Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association","volume":"34","author":"Takagi","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-022-03000-w_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s40336-014-0070-2","article-title":"The role of PET quantification in cardiovascular imaging","volume":"2","author":"Slomka","year":"2014","journal-title":"Clin Transl Imaging"},{"key":"10.1007\/s12350-022-03000-w_bib34","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.114.002481","article-title":"Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women\u2019s Ischemia Syndrome Evaluation","author":"Thomson","year":"2015","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1007\/s12350-022-03000-w_bib35","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1161\/CIRCULATIONAHA.117.029992","article-title":"Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease","volume":"136","author":"Gupta","year":"2017","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib36","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.119.044666","article-title":"The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping","author":"Knott","year":"2020","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib37","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.echo.2011.03.010","article-title":"Coronary flow velocity reserve in the three main coronary arteries assessed with transthoracic Doppler: a comparative study with quantitative coronary angiography","volume":"24","author":"Vegsundv\u00e5g","year":"2011","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1007\/s12350-022-03000-w_bib38","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0140-6736(21)02045-6","article-title":"What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?","volume":"399","author":"Boden","year":"2022","journal-title":"Lancet"},{"key":"10.1007\/s12350-022-03000-w_bib39","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","article-title":"Optimal medical therapy with or without pci for stable coronary disease","volume":"356","author":"Boden","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1007\/s12350-022-03000-w_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/1479164109354145","article-title":"The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease","volume":"7","author":"Rutter","year":"2010","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1007\/s12350-022-03000-w_bib41","doi-asserted-by":"crossref","DOI":"10.1007\/s11936-018-0667-2","article-title":"Cardiac rehabilitation and exercise prescription in symptomatic patients with non-obstructive coronary artery disease-a systematic review","author":"Kissel","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1007\/s12350-022-03000-w_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ahj.2021.03.011","article-title":"Rationale and design of the Women\u2019s Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial","volume":"237","author":"Handberg","year":"2021","journal-title":"Am Heart J"},{"key":"10.1007\/s12350-022-03000-w_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10557-013-6439-z","article-title":"Lack of effect of nitrates on exercise stress test results in patients with microvascular angina","volume":"27","author":"Russo","year":"2013","journal-title":"Cardiovasc drugs Ther"},{"key":"10.1007\/s12350-022-03000-w_bib44","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/CIRCULATIONAHA.118.031373","article-title":"Reappraisal of ischemic heart disease: Fundamental role of coronary microvascular dysfunction in the pathogenesis of angina pectoris","volume":"138","author":"Kaski","year":"2018","journal-title":"Circulation"},{"key":"10.1007\/s12350-022-03000-w_bib45","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ahj.2011.07.011","volume":"162","author":"Pauly","year":"2011","journal-title":"Am Heart J."},{"key":"10.1007\/s12350-022-03000-w_bib46","first-page":"60602","article-title":"Management of ischaemia with non-obstructive coronary arteries (INOCA)","volume":"375","author":"Beltrame","year":"2021","journal-title":"BMJ."},{"key":"10.1007\/s12350-022-03000-w_bib47","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cjco.2020.09.005","article-title":"Efficacy of ranolazine for treatment of coronary microvascular dysfunction\u2014a systematic review and meta-analysis of randomized trials","volume":"3","author":"Kofler","year":"2021","journal-title":"CJC Open"},{"key":"10.1007\/s12350-022-03000-w_bib48","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1093\/eurheartj\/ehw021","article-title":"Treatment of microvascular angina: the need for precision medicine","volume":"37","author":"Crea","year":"2016","journal-title":"Eur Heart J"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-022-03000-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123007225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123007225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-022-03000-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:45:10Z","timestamp":1735573510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123007225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1071358123007225"],"URL":"https:\/\/doi.org\/10.1007\/s12350-022-03000-w","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotype-based management of coronary microvascular dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-022-03000-w","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by ELSEVIER INC. on behalf of American Society of Nuclear Cardiology. Published by Mosby, Inc.","name":"copyright","label":"Copyright"}]}}